Dr. Afsaneh Motamed-Khorasani, Ph.D. to be Profiled in Exclusive Registry
Dr. Motamed-Khorasani has a diverse background in clinical trials, basic research, intellectual property, and industry

Toronto, ON, Canada, December 27, 2010 /24-7PressRelease/ -- Afsaneh Motamed-Khorasani, CEO and Director of Medical Communication at Neometrix Consulting Inc. (NCI), has been recognized by Cambridge Who's Who for demonstrating scientific dedication, leadership and excellence in medical communication and research.

Dr. Motamed-Khorasani has 15 years of professional experience in the field of scientific research and medical communication. As a CEO and Director of Medical Communication at NCI, she oversees all aspects of company activities including medical communication, marketing and client relations. She attributes her success to her passion for science, personal optimism and networking skills.

While earning a Ph.D. in oncology, Dr. Motamed-Khorasani was honored with numerous fellowships and awards of excellence at the University of British Columbia and the University of Toronto. Her many affiliations include American Association of Cancer Research (AACR), Endocrine Society, The Intellectual Property Institute of Canada (IPIC), The Toronto Biotechnology Initiative (TBI) and The Iranian-American Medical Association (IAMA). A supporter of the Heart and Stroke Foundation of Canada, Dr. Motamed-Khorasani intends to continue consulting at the international level.

Neometrix Consulting Inc. is a Canadian based consultancy offering medical communication and medical intelligence services to the pharmaceutical, biotechnology, and medical device companies, clinics, hospitals, contract research organizations (CRO), government agencies, and academic institutes. It strives to develop strategic platforms and processes, enabling clients to make highly informed decisions, reduce costs, create value and improve performance. The clinical areas of NCI expertise are oncology, hepatology, immunology, bone health, rheumatoid arthritis, blood products, neurology, cardiology, infectious disease, diabetes, urology, reproductive medicine, and pharmacogenetics. For more information, visit http://neometrixconsulting.com.

Press Release Contact Information:

Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website